Regulatory authorities are increasingly recommending adjudication of safety and efficacy events, such as interstitial lung disease (ILD), in clinical trials. To meet this requirement, trial sponsors turn to independent clinical event committees (CECs) as the most efficient way to help reduce costs, increase quality, and eliminate clinical bias. Leading pulmonologist Dr. Charles Powell is the chair of a CEC that adjudicates ILD events in a drug cancer therapy trial. The CEC has identified distinct patterns of ILD that differed in terms of the time of onset and severity.

In the webinar, we will discuss:

  • Event adjudication objectives and the role and value of the CEC as an unbiased entity in the drug development process
  • Unexpected observations that enabled the sponsor to design new studies, modify data collection, and create education and training programs to identify and treat ILD
  • Critical components of the adjudication program that gave the committee members the platform to perform an accurate and timely review of findings

Register today to learn what to look for in a trusted adjudication partner for your next study.

Featured Speakers

Charles A. Powell, MD, MBA

CEO
Mount Sinai-National Jewish Health Respiratory Institute

Dr. Powell is Professor of Medicine and System Division Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai in New York and Medical Director of Respiratory Therapy at Mount Sinai Hospital. He received his medical degree at University of Chicago and trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine and Boston University. He is the CEO of the Mount Sinai-National Jewish Health Respiratory Institute that is a partnership of The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital based in Denver.

Janine Jones, RN, MBA

Senior Product Manager – Specialty Solutions
Bioclinica

Janine works as a Senior Product Manager at Bioclinica managing the Clinical Adjudication System. She helps drive the product vision by seeking to understand the unique needs of clients at a deep level. Janine spent three years as the account manager for large adjudication clients at IBM. Prior to her entry into the field of clinical trial technologies, she led patient safety initiatives at a large hospital system for 14 years. Janine received her nursing degree from the University of North Carolina at Greensboro and her MBA from Walden University in Minneapolis.

NOW AVAILABLE ON-DEMAND

Register now for this webinar